NSAIDs for Skin Cancer Prevention

LISA SCHULMEISTER, RN, MN, APRN-BC, OCN, FAAN
Thursday, May 31, 2012
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
It is well recognized that non-steroidal anti-inflammatory drugs (NSAIDs) may prevent the development of cancer by inhibiting cyclooxygenase (COX) enzymes, which are involved in carcinogenesis. Researchers in Denmark examined the association between NSAID use and the risk of squamous cell carcinoma (SCC), basal cell carcinoma (BCC), and malignant melanoma (MM). From 1991-2009, all cases of SCC (n = 1974), BCC (n = 13,316), and MM (n = 3242) in northern Denmark were identified. Ten population controls (n = 178,655) were matched to each case by age, gender, and county of residence. A prescription database was used to ascertain the use of aspirin, other nonselective NSAIDs, or selective COX-2 inhibitors.

For NSAIDs overall, ever use (>2 prescriptions) compared with nonuse (≤2 prescriptions) was associated with a decreased risk of SCC (IRR, 0.85) and MM (IRR, 0.87), especially for long-term use (≥7 years) and high-intensity use (>25% prescription coverage during the total duration of use). NSAID use was not associated with a reduced risk of BCC overall (IRR, 0.97), but the risk of BCC at sites other than the head and neck was reduced in association with long-term use (IRR, 0.85) and high-intensity use (IRR, 0.79). When the researchers looked specifically at people who had filled prescriptions for the drugs over at least seven years, and used them twice a week or more, they found a stronger link: long-term, high-frequency NSAID users had a 46% lower risk of melanoma, a 35% lower risk of squamous cell carcinoma, and a 17% lower risk of basal cell carcinoma.

These findings add to growing evidence that long-term use of NSAIDs may help protect people against skin cancers, including melanoma. However, NSAIDs also are associated with risks, such as bleeding. The best defense against developing skin cancer is non-pharmacologic—sun protection.
Reference
Johannesdottir SA, Chang ET, Mehnert F, et al. Nonsteroidal and anti-inflammatory drugs and the risk of cancer: A population based case-control study. Cancer. 2012. Article first published online: 29 MAY 2012 | DOI: 10.1002/cncr.27406


Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
 
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
 
 
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.